Molecular targeted therapy for anticancer treatment

HY Min, HY Lee - Experimental & Molecular Medicine, 2022 - nature.com
Since the initial clinical approval in the late 1990s and remarkable anticancer effects for
certain types of cancer, molecular targeted therapy utilizing small molecule agents or …

Emerging strategies to overcome resistance to third-generation EGFR inhibitors

K Shi, G Wang, J Pei, J Zhang, J Wang… - Journal of Hematology & …, 2022 - Springer
Epidermal growth factor receptor (EGFR), the receptor for members of the epidermal growth
factor family, regulates cell proliferation and signal transduction; moreover, EGFR is related …

20 years since the approval of first EGFR-TKI, gefitinib: Insight and foresight

S Singh, S Sadhukhan, A Sonawane - Biochimica et Biophysica Acta (BBA) …, 2023 - Elsevier
Epidermal growth factor receptor (EGFR) actively involves in modulation of various cancer
progression related mechanisms including angiogenesis, differentiation and migration …

Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth …

R Pal, G Teli, GSP Matada, PS Dhiwar - Journal of Molecular Structure, 2023 - Elsevier
Cancer cells have the ability of dysregulation and autonomous proliferation due to
unchecked production of definite molecules. These molecules are involved in the cell growth …

[HTML][HTML] Targeted inhibitors of EGFR: structure, biology, biomarkers, and clinical applications

N Shaban, D Kamashev, A Emelianova, A Buzdin - Cells, 2023 - mdpi.com
Members of the EGFR family of tyrosine kinase receptors are major regulators of cellular
proliferation, differentiation, and survival. In humans, abnormal activation of EGFR is …

Implicative role of epidermal growth factor receptor and its associated signaling partners in the pathogenesis of Alzheimer's disease

PK Jayaswamy, M Vijaykrishnaraj, P Patil… - Ageing Research …, 2023 - Elsevier
Epidermal growth factor receptor (EGFR) plays a pivotal role in early brain development,
although its expression pattern declines in accordance with the maturation of the active …

An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)

R Pal, G Teli, S Sengupta, L Maji… - Journal of …, 2024 - Taylor & Francis
Almost 80% of lung cancer diagnoses each year correspond to non-small cell lung cancer
(NSCLC). The percentage of NSCLC with EGFR overexpression ranges from 40% to 89 …

[HTML][HTML] Advances in personalized oncology

H Mechahougui, J Gutmans, G Colarusso, R Gouasmi… - Cancers, 2024 - mdpi.com
Simple Summary Advances in next-generation sequencing have initiated a paradigm shift in
cancer treatment, transitioning from traditional, organ-specific protocols to precision …

Nitrogen‐Containing Heterocyclic Scaffolds as EGFR Inhibitors: Design Approaches, Molecular Docking, and Structure‐Activity Relationships

R Pal, G Teli, G Swamy Purawarga Matada… - …, 2023 - Wiley Online Library
Cancer is a wide collection of diseases and among the numerous pathways involved in
cancer pathogenesis, pathway involving epidermal growth factor receptor (EGFR) is one of …

Tieing together loose ends: telomere instability in cancer and aging

G Borges, M Criqui, L Harrington - Molecular Oncology, 2022 - Wiley Online Library
Telomere maintenance is essential for maintaining genome integrity in both normal and
cancer cells. Without functional telomeres, chromosomes lose their protective structure and …